Tumor targeting IgE’s are being developed in an attempt to harness the diverse acquired responses mediated through IgE (e.g. parasite expulsion), the success of targeting cancer tumor markers with humanized IgG as a therapeutic strategy (42), and the epidemiological evidence suggesting a protective role for atopy against some malignancies (43). Here, IGHE is linked to cancer.